Phase Holographic Imaging PHI AB (FRA:L5W) EBITDA Margin %: -1,771.43% (As of Oct. 2025)

What is Phase Holographic Imaging PHI AB EBITDA Margin %?

Phase Holographic Imaging PHI AB FRA:L5W EBITDA Margin % is -1,771.43% as of Oct. 2025. The stock has 5 warning signs investors should review.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Phase Holographic Imaging PHI AB's EBITDA for the three months ended in Oct. 2025 was €-0.50 Mil. Phase Holographic Imaging PHI AB's Revenue for the three months ended in Oct. 2025 was €0.03 Mil. Therefore, Phase Holographic Imaging PHI AB's EBITDA margin for the quarter that ended in Oct. 2025 was -1,771.43%.

Phase Holographic Imaging PHI AB (FRA:L5W) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Phase Holographic Imaging PHI AB EBITDA Margin % Related Terms

Phase Holographic Imaging PHI AB EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Phase Holographic Imaging PHI AB's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phase Holographic Imaging PHI AB EBITDA Margin % Chart

Phase Holographic Imaging PHI AB Annual Data

Trend

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Apr25

EBITDA Margin %

Get a 7-Day Free Trial

-458.10

-183.31

-170.41

-127.81

-72.25

Phase Holographic Imaging PHI AB Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25
EBITDA Margin %	Get a 7-Day Free Trial															-93.49	-15.22	-60.98	-1,906.06	-1,771.43

FRA:L5W vs ABT, BSX, SYK: EBITDA Margin % Comparison

For the Medical Devices subindustry, Phase Holographic Imaging PHI AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phase Holographic Imaging PHI AB EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Phase Holographic Imaging PHI AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Phase Holographic Imaging PHI AB's EBITDA Margin % falls into.

Save Embed

Phase Holographic Imaging PHI AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Phase Holographic Imaging PHI AB's EBITDA Margin % for the fiscal year that ended in Apr. 2025 is calculated as

EBITDA Margin %	=	EBITDA (A: Apr. 2025 )	/	Revenue (A: Apr. 2025 )
	=	-1.096	/	1.517
	=	-72.25 %

Phase Holographic Imaging PHI AB's EBITDA Margin % for the quarter that ended in Oct. 2025 is calculated as

EBITDA Margin %	=	EBITDA (Q: Oct. 2025 )	/	Revenue (Q: Oct. 2025 )
	=	-0.496	/	0.028
	=	-1,771.43 %

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of -1,771.43% mean?

Phase Holographic Imaging PHI AB (FRA:L5W) has a EBITDA Margin % of -1,771.43% as of Oct. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Phase Holographic Imaging PHI AB and its competitors.

Is Phase Holographic Imaging PHI AB's EBITDA Margin % too high?

Phase Holographic Imaging PHI AB's current EBITDA Margin % is -1,771.43%.

How does Phase Holographic Imaging PHI AB's EBITDA Margin % compare to ABT and BSX?

Phase Holographic Imaging PHI AB's EBITDA Margin % of -1,771.43% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Medical Devices & Instruments company?

The median EBITDA Margin % among Medical Devices & Instruments companies is 7.39, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Phase Holographic Imaging PHI AB and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phase Holographic Imaging PHI AB's current EBITDA Margin % is -1,771.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Phase Holographic Imaging PHI AB stock overvalued right now?

Phase Holographic Imaging PHI AB (FRA:L5W) has a current EBITDA Margin % of -1,771.43%. The stock's GF Value™ is €0.23, compared to a current price of €0.04 — trading 81% below its estimated fair value. The current EBITDA Margin % is -1,771.43%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (FRA:L5W), the current EBITDA Margin % is -1,771.43% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phase Holographic Imaging PHI AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSTO:QLIFE XSAT:IMS XSAT:PEXA B XSAT:VSD B XSAT:POLAR OSTO:SPEC XSAT:ZENI XSAT:MONI OSTO:PERP B XSAT:SDET ABT BSX SYK MDT XTER:SHL EW GEHC SZSE:300760 DXCM XAMS:PHIA

Address Skiffervagen 48, Lund, SWE, 224 78

Website https://www.phiab.com

Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.